NCT04688801View on ClinicalTrials.gov

Ajuvant Chemotherapy and Immunotherapy in Patients With Esophageal, Esophageal- Gastric Junction Cancer

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2020

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2027

Conditions
Esophageal CancerGastroesophageal CancerImmunotherapyAdjuvant
Interventions
DRUG

Chemotherapy Drugs, Cancer

Chemotherapy± Radiotherapy after surgery

DRUG

Immunotherapy

Chemotherapy + Immuonotherapy ± Radiotherapy after surgery

Trial Locations (1)

250033

RECRUITING

The Second Hospital of Shandong University, Jinan

All Listed Sponsors
lead

The Second Hospital of Shandong University

OTHER